https://www.gosh.nhs.uk/news/internationally-renowned-gosh-clinician-and-researcher-takes-up-post-as-director-of-ucl-great-ormond-street-institute-of-child-health/
New director of UCL Great Ormond Street Institute of Child Health
30 Jun 2022, 5 p.m.
The UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have announced that Professor Helen Cross, an Honorary Consultant in Paediatric Neurology at GOSH, will take up the post of Director of the institute from 1 September 2022.
The UCL GOS ICH is our primary research partner at Great Ormond Street Hospital (GOSH). Together we form the largest centre for paediatric medical research outside North America. Research teams and clinicians work together across our organisations to further our Research Hospital vision.
As well as her role as an Honorary Consultant in Paediatric Neurology at GOSH, Professor Cross is The Prince of Wales’s Chair of Childhood Epilepsy and Head of the Developmental Neurosciences Research and Teaching Department at UCL GOS ICH. The primary focus of her research has been optimising outcomes in the early onset epilepsies, working extensively with patient advocacy groups.
It is an honour and a privilege to have been appointed Director of UCL Great Ormond Street Institute of Child Health. Having spent most of my career at GOSH and the UCL GOS ICH, I am passionate about maintaining the excellence in research and education achieved to date, sharing with others, and so optimising the health and well-being of children.
Professor Cross is internationally recognised for her work in pre-surgical evaluation and monitoring postsurgical outcomes in children undergoing epilepsy surgery. She is also renowned for her work on the ketogenic diet as a treatment for epilepsy which is now part of NICE guidelines.
In 2015 she was awarded an OBE for services to children with epilepsy and has received awards from around the world that recognised her contribution to research and clinical care for children with epilepsy. Prof Cross was the first, and to date the only woman, to be elected as President of the British Paediatric Neurology Association (2008), and in 2013, the first woman to be elected to the management committee of the International League Against Epilepsy, where she has since been elected as President.
We are delighted to welcome Professor Helen Cross as Director of the UCL GOS Institute of Child Health, our primary research partner. As an established leading researcher and Honorary Consultant at GOSH, Helen is passionate about our Research Hospital vision. I am very much looking forward to working with her even more closely as we continue the excellent relationship that brings to life our vision for children at GOSH and around the world.
NIHR launches £13.7m investment into brain tumour research
The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.
New consortium aims to help improve care for arthritis patients
A new UK-led research group, including Great Ormond Street Hospital and University College London, aims to improve the lives of children, young people and adults with arthritis by defining for the first time what being in ‘remission’ from arthritis truly
Update for patients and families on industrial action - December 2025
As you may be aware, some of our Resident Doctors will be taking part in planned industrial action from 7am on Wednesday 17 December to 7am on Monday 22 December.
‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia
A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer